Nephros Inc
NASDAQ:NEPH

Watchlist Manager
Nephros Inc Logo
Nephros Inc
NASDAQ:NEPH
Watchlist
Price: 3.8 USD -3.31%
Market Cap: $40.4m

Nephros Inc
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Nephros Inc
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Nephros Inc
NASDAQ:NEPH
Intangible Assets
$501k
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Whirlpool Corp
NYSE:WHR
Intangible Assets
$2.6B
CAGR 3-Years
-7%
CAGR 5-Years
3%
CAGR 10-Years
0%
Hamilton Beach Brands Holding Co
NYSE:HBB
Intangible Assets
$2.1m
CAGR 3-Years
12%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Cricut Inc
NASDAQ:CRCT
Intangible Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vesync Co Ltd
HKEX:2148
Intangible Assets
$218k
CAGR 3-Years
-9%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Sharkninja Inc
NYSE:SN
Intangible Assets
$451.1m
CAGR 3-Years
-3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Nephros Inc
Glance View

Market Cap
40.4m USD
Industry
Consumer products

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.

NEPH Intrinsic Value
2.76 USD
Overvaluation 27%
Intrinsic Value
Price

See Also

What is Nephros Inc's Intangible Assets?
Intangible Assets
501k USD

Based on the financial report for Sep 30, 2025, Nephros Inc's Intangible Assets amounts to 501k USD.

What is Nephros Inc's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-16%

Over the last year, the Intangible Assets growth was -15%. The average annual Intangible Assets growth rates for Nephros Inc have been -17% over the past three years , -16% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett